Annual Cash & Cash Equivalents
$51.58 M
-$13.24 M-20.43%
December 31, 2023
Summary
- As of February 7, 2025, VTYX annual cash & cash equivalents is $51.58 million, with the most recent change of -$13.24 million (-20.43%) on December 31, 2023.
- During the last 3 years, VTYX annual cash & cash equivalents has risen by +$51.34 million (+21038.93%).
- VTYX annual cash & cash equivalents is now -27.14% below its all-time high of $70.79 million, reached on December 31, 2021.
Performance
VTYX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$61.77 M
+$20.84 M+50.92%
September 30, 2024
Summary
- As of February 7, 2025, VTYX quarterly cash and cash equivalents is $61.77 million, with the most recent change of +$20.84 million (+50.92%) on September 30, 2024.
- Over the past year, VTYX quarterly cash and cash equivalents has dropped by -$80.13 million (-56.47%).
- VTYX quarterly cash and cash equivalents is now -76.54% below its all-time high of $263.27 million, reached on September 30, 2022.
Performance
VTYX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VTYX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.4% | -56.5% |
| 3 y3 years | +10000.0% | -56.5% |
| 5 y5 years | +10000.0% | -56.5% |
VTYX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.1% | at low | -76.5% | +50.9% |
| 5 y | 5-year | -27.1% | >+9999.0% | -76.5% | >+9999.0% |
| alltime | all time | -27.1% | >+9999.0% | -76.5% | >+9999.0% |
Ventyx Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $61.77 M(+50.9%) |
| Jun 2024 | - | $40.92 M(-71.2%) |
| Mar 2024 | - | $141.90 M(+175.1%) |
| Dec 2023 | $51.58 M(-20.4%) | $51.58 M(-8.9%) |
| Sep 2023 | - | $56.61 M(+9.5%) |
| Jun 2023 | - | $51.72 M(-18.8%) |
| Mar 2023 | - | $63.67 M(-1.8%) |
| Dec 2022 | $64.82 M | $64.82 M(-75.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $263.27 M(+480.6%) |
| Jun 2022 | - | $45.34 M(+8.8%) |
| Mar 2022 | - | $41.69 M(-41.1%) |
| Dec 2021 | $70.79 M(>+9900.0%) | $70.79 M(+2.6%) |
| Sep 2021 | - | $68.99 M(-32.9%) |
| Jun 2021 | - | $102.79 M(>+9900.0%) |
| Dec 2020 | $244.00 K(-21.0%) | $244.00 K |
| Dec 2019 | $309.00 K | - |
FAQ
- What is Ventyx Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ventyx Biosciences?
- What is Ventyx Biosciences annual cash & cash equivalents year-on-year change?
- What is Ventyx Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ventyx Biosciences?
- What is Ventyx Biosciences quarterly cash and cash equivalents year-on-year change?
What is Ventyx Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of VTYX is $51.58 M
What is the all time high annual cash & cash equivalents for Ventyx Biosciences?
Ventyx Biosciences all-time high annual cash & cash equivalents is $70.79 M
What is Ventyx Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, VTYX annual cash & cash equivalents has changed by -$13.24 M (-20.43%)
What is Ventyx Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VTYX is $61.77 M
What is the all time high quarterly cash and cash equivalents for Ventyx Biosciences?
Ventyx Biosciences all-time high quarterly cash and cash equivalents is $263.27 M
What is Ventyx Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, VTYX quarterly cash and cash equivalents has changed by -$80.13 M (-56.47%)